Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. (Q48674231)
Jump to navigation
Jump to search
scientific article published in December 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. |
scientific article published in December 2012 |
Statements
1 reference
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. (English)
1 reference
1 reference
Fernando Torres
1 reference
Victor F Tapson
1 reference
Fiona Kermeen
1 reference
Anne M Keogh
1 reference
Roblee P Allen
1 reference
Robert P Frantz
1 reference
David B Badesch
1 reference
Adaani E Frost
1 reference
Shelley M Shapiro
1 reference
Kevin Laliberte
1 reference
Jeffrey Sigman
1 reference
Carl Arneson
1 reference
1 December 2012
1 reference
1 reference
142
1 reference
6
1 reference
1383-1390
1 reference
Identifiers
1 reference
1 reference